We are live on ! Find out more
ECM

EagleClaw Capital Management Portfolio holdings

AUM $714M
1-Year Est. Return 24.24%
This Fund
S&P 500
This Quarter Est. Return
+13.95%
1 Year Est. Return
+24.24%
3 Year Est. Return
+96.54%
5 Year Est. Return
+138.84%
10 Year Est. Return
+573.51%
AUM
$348M
AUM Growth
+$33.5M
Cap. Flow
+$5.5M
Cap. Flow %
1.58%
Top 10 Hldgs %
36.46%
Holding
130
New
3
Increased
55
Reduced
48
Closed
2

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$2.94M
2
APD icon
Air Products & Chemicals
APD
+$1.92M
3
GEN icon
Gen Digital
GEN
+$1.84M
4
FNV icon
Franco-Nevada
FNV
+$975K
5
LMT icon
Lockheed Martin
LMT
+$618K

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$1.71M
2
FMC icon
FMC
FMC
+$1.47M
3
CERN
Cerner Corp
CERN
+$1.18M
4
NKE icon
Nike
NKE
+$784K
5
AAPL icon
Apple
AAPL
+$655K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.28%
2 Technology 16.35%
3 Financials 14.75%
4 Industrials 12.85%
5 Healthcare 11.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTC icon
26
Intel
INTC
$455B
$4.17M 1.2%
65,231
-28,698
-31% -$1.71M
FNV icon
27
Franco-Nevada
FNV
$41.1B
$3.88M 1.12%
30,940
+8,100
+35% +$975K
BMY icon
28
Bristol-Myers Squibb
BMY
$133B
$3.72M 1.07%
58,847
+7,210
+14% +$449K
SBUX icon
29
Starbucks
SBUX
$120B
$3.71M 1.07%
33,965
+930
+3% +$97.6K
LMT icon
30
Lockheed Martin
LMT
$134B
$3.51M 1.01%
9,525
+1,800
+23% +$618K
BRK.B icon
31
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.47M 1%
13,572
-50
-0.4% -$12.1K
CVX icon
32
Chevron
CVX
$392B
$3.44M 0.99%
32,841
+6,080
+23% +$594K
TMO icon
33
Thermo Fisher Scientific
TMO
$213B
$3.34M 0.96%
7,313
-37
-0.5% -$17.7K
BAC icon
34
Bank of America
BAC
$435B
$3.28M 0.94%
84,752
+18
+0% +$621
ORCL icon
35
Oracle
ORCL
$374B
$3.19M 0.92%
+45,462
New +$2.94M
CI icon
36
Cigna
CI
$73.7B
$2.98M 0.86%
12,325
+780
+7% +$174K
HON icon
37
Honeywell
HON
$77B
$2.97M 0.85%
14,510
+700
+5% +$137K
CAT icon
38
Caterpillar
CAT
$375B
$2.94M 0.84%
12,675
-50
-0.4% -$10.4K
HOLX
39
DELISTED
Hologic
HOLX
$2.84M 0.82%
38,175
-400
-1% -$30.4K
GOOGL icon
40
Alphabet (Google) Class A
GOOGL
$4.36T
$2.79M 0.8%
27,020
-1,380
-5% -$136K
GILD icon
41
Gilead Sciences
GILD
$162B
$2.67M 0.77%
41,262
+2,149
+5% +$139K
JNJ icon
42
Johnson & Johnson
JNJ
$618B
$2.52M 0.73%
15,369
+250
+2% +$40.5K
PCH
43
DELISTED
PotlatchDeltic
PCH
$2.52M 0.72%
47,600
+775
+2% +$40K
NVO
44
Novo Nordisk
NVO
$208B
$2.48M 0.71%
73,550
+2,650
+4% +$94.4K
MSGS icon
45
Madison Square Garden
MSGS
$9.48B
$2.43M 0.7%
13,580
+50
+0.4% +$9.22K
IBM icon
46
IBM
IBM
$211B
$2.43M 0.7%
19,032
+811
+4% +$97.1K
MRK icon
47
Merck
MRK
$322B
$2.4M 0.69%
32,710
+2,468
+8% +$182K
CL icon
48
Colgate-Palmolive
CL
$73.1B
$2.4M 0.69%
30,361
+908
+3% +$71.2K
TXN icon
49
Texas Instruments
TXN
$252B
$2.22M 0.64%
11,770
-40
-0.3% -$6.95K
EMR icon
50
Emerson Electric
EMR
$83.9B
$2.22M 0.64%
24,563
+1,250
+5% +$108K

Similar funds

EagleClaw Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, EagleClaw Capital Management held 130 positions worth $348M, up 11% from $314M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Trading was light in Q1 2021: portfolio turnover was 3.8%. EagleClaw Capital Management opened 3 new positions and exited 2, leaving the 130-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • EagleClaw Capital Management's largest Q1 2021 buy was Oracle: 45,462 shares worth $3.19M.
  • EagleClaw Capital Management added most to Air Products & Chemicals in Q1 2021, an estimated $1.92M increase.
  • EagleClaw Capital Management's biggest Q1 2021 reduction was Intel, cutting an estimated $1.71M.
  • EagleClaw Capital Management fully exited ProShares S&P 500 Dividend Aristocrats ETF in Q1 2021, selling an estimated $205K.
  • EagleClaw Capital Management's ten largest holdings make up 36% of its $348M portfolio in Q1 2021.
  • EagleClaw Capital Management opened 3 new positions and closed 2 in Q1 2021.
  • EagleClaw Capital Management's portfolio value rose 11% quarter-over-quarter to $348M.

Based on EagleClaw Capital Management's 13F filing for Q1 2021, filed 12 May 2021.